Table 5.
Results of antimicrobial susceptibility testing.
| Antibiotic agents tested | Antimicrobial class | Number of resistant strains, n = 37 |
|---|---|---|
| Amoxicillin/clavulanic acid (AUG2) | β-Lactam combination agents | 8 (21.6%) |
| Ampicillin (AMP) | Penicillins | 16 (43.2%) |
| Azithromycin (AZI) | Macrolides | 0 |
| Cefoxitin (FOX) | Cephems | 8 (21.6%) |
| Ceftriaxone (AXO) | Cephems | 8 (21.6%) |
| Chloramphenicol (CHL) | Phenicols | 0 |
| Ciprofloxacin (CIP) | Quinolones | 0 |
| Gentamicin (GEN) | Aminoglycosides | 17 (45.9%) |
| Meropenem (MERO) | Penems | 0 |
| Nalidixic Acid (NAL) | Quinolones | 0 |
| Streptomycin (STR) | Aminoglycosides | 11 (29.7%) |
| Sulfisoxazole (FIS) | Folate pathway antagonists | 11 (29.7%) |
| Tetracycline (TET) | Tetracyclines | 23 (62.2%) |
| Trimethoprim/sulfamethoxazole (SXT) | Folate pathway antagonists | 6 (16.2%) |